Maravai LifeSciences Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Maravai LifeSciences Holdings has a total shareholder equity of $777.4M and total debt of $523.3M, which brings its debt-to-equity ratio to 67.3%. Its total assets and total liabilities are $1.4B and $667.3M respectively.
Key information
67.3%
Debt to equity ratio
US$523.33m
Debt
Interest coverage ratio | n/a |
Cash | US$561.69m |
Equity | US$777.39m |
Total liabilities | US$667.25m |
Total assets | US$1.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MAR's short term assets ($667.9M) exceed its short term liabilities ($59.0M).
Long Term Liabilities: MAR's short term assets ($667.9M) exceed its long term liabilities ($608.2M).
Debt to Equity History and Analysis
Debt Level: MAR has more cash than its total debt.
Reducing Debt: MAR's debt to equity ratio has reduced from 229.6% to 67.3% over the past 5 years.
Debt Coverage: MAR's debt is not well covered by operating cash flow (6.2%).
Interest Coverage: Insufficient data to determine if MAR's interest payments on its debt are well covered by EBIT.